Prospective assessment of venous thromboembolism in lung cancer patients using a standardized screening protocol
Monaldi Archives for Chest Disease · 2025
DOI: 10.4081/monaldi.2025.3293 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Monaldi Archives for Chest Disease, 2025. Verfasst von Pedro Magalhães Ferreira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Department, University Hospital Center of São João, Porto. Hauptthemen laut MEDLINE: Venous Thromboembolism, Lung Neoplasms, Mass Screening. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Thromboseprophylaxe, Onkologische Pflege
Abstract (Originalsprache)
Venous thromboembolism (VTE) is highly prevalent in cancer patients. While its actual incidence remains disparate among studies, specific subpopulations, such as lung cancer patients, might be at an increased risk. We aimed to assess the impact of a screening protocol in determining both the incidence and risk factors for VTE and evaluate the usefulness of predictive biomarkers and risk stratification tools in lung cancer patients. For this purpose, we designed a prospective cohort study including all consecutive, newly diagnosed lung cancer patients between October 2023 and April 2024 in a tertiary center and assessed each patient using a standardized screening protocol. VTE screening included baseline and 3-month reassessment of coagulation tests, D-dimer levels, and imaging (duplex ultrasound of the lower limbs for deep vein thrombosis screening and contrast-enhanced thoracic computed tomography for pulmonary embolism screening). A total of 102 patients were included, of which 16 (15.7%) were diagnosed with VTE. VTE was more frequent in males (p=0.031), patients with COPD (p=0.004), and patients with metastatic disease (p=0.038), particularly those under immunotherapy (p=0.026). Patients with VTE presented a D-dimer concentration more than three times higher at baseline and fivefold the levels observed in non-VTE patients at 3 months (p=0.002). Paired with Khorana scores, D-dimer concentration 4.5 mg/L at 3 months improved the predictive capacity of this VTE risk assessment tool in patients under active treatment. Active VTE screening yielded a significant increase in diagnosis, suggesting the incidence of this complication in newly diagnosed lung cancer patients is underestimated. Risk assessment tools can be enhanced by the addition of D-dimer-based parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonology Department, University Hospital Center of São João, Porto.
- Pulmonology Department, University Hospital Center of São João, Porto; Faculty of Medicine, University of Porto.
- Pulmonology Department, University Hospital Center of São João, Porto; Faculty of Medicine, University of Porto; Institute of Molecular Pathology and Immunology, University of Porto.
ORCID-Profile: Pedro Magalhães Ferreira, Joana Ferreira, Catarina Sousa, David Araújo, Hélder Novais Bastos
Zitieren
APA
Magalhães Ferreira, P., Ferreira, J., Freitas, C., Sousa, C., Araújo, D., Novais Bastos, H., Magalhães, A., & Fernandes, M. G. (2025). Prospective assessment of venous thromboembolism in lung cancer patients using a standardized screening protocol. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2025.3293
Vancouver
Magalhães Ferreira P, Ferreira J, Freitas C, Sousa C, Araújo D, Novais Bastos H, et al. Prospective assessment of venous thromboembolism in lung cancer patients using a standardized screening protocol. Monaldi Archives for Chest Disease. 2025. doi:10.4081/monaldi.2025.3293
BibTeX
@article{MagalhesFerreira2025,
author = {Magalhães Ferreira, Pedro and Ferreira, Joana and Freitas, Cláudia and Sousa, Catarina and Araújo, David and Novais Bastos, Hélder and Magalhães, Adriana and Fernandes, Maria Gabriela},
title = {Prospective assessment of venous thromboembolism in lung cancer patients using a standardized screening protocol},
journal = {Monaldi Archives for Chest Disease},
year = {2025},
doi = {10.4081/monaldi.2025.3293}
}
EUVIMED